Skip to content
Screener

Cardiff Oncology CRDF Q2 2026 earnings

Reported August 11, 2026 · After market close

Revenue$104.0KBeat by $41.2K
EPS-$0.14Miss by $0.02
Revenue estimate$62.8K
EPS estimate-$0.12

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$67.2K
EPS estimate-$0.15

FAQ

When did Cardiff Oncology report Q2 2026 earnings?
Cardiff Oncology (CRDF) reported Q2 2026 earnings on August 11, 2026 after market close.
What were Cardiff Oncology's Q2 2026 revenue and EPS?
Cardiff Oncology reported revenue of $104.0K and eps of $-0.14 for Q2 2026.
Did Cardiff Oncology beat estimates in Q2 2026?
Revenue beat the consensus estimate of $62.8K by $41.2K. EPS missed the consensus estimate of $-0.12 by $0.02.
How did Cardiff Oncology's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 14.0% from $121.0K a year earlier and eps grew 33.3% from $-0.21.
Where can I find Cardiff Oncology's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-344645) and the 10-Q periodic report (0001193125-26-344545) directly on SEC EDGAR. The filing index links above go to sec.gov.